1. New evidence for a presynaptic action of prednisolone at neuromuscular junctions
- Author
-
Cháriston André, Dal Belo, Gildo Bernardo, Leite, Marcos Dias, Fontana, Alexandre Pinto, Corrado, Ana Cristina, Zanandréa Baso, Carmen Sílvia, Moreno Serra, Antonio Carlos, Oliveira, and Léa, Rodrigues-Simioni
- Subjects
Male ,Prednisolone ,Diaphragm ,Neuromuscular Junction ,Presynaptic Terminals ,In Vitro Techniques ,Sciatic Nerve ,Membrane Potentials ,Rats ,Phrenic Nerve ,Mice ,Animals ,Neuromuscular Blocking Agents ,Rats, Wistar ,Muscle, Skeletal - Abstract
The action of prednisolone at the neuromuscular junction was studied in mouse isolated phrenic nerve-diaphragm and rat external popliteal/sciatic nerve-tibialis anterior muscle preparations. Prednisolone (0.03 mM and 0.3 mM) did not alter the twitch-tension in phrenic nerve-diaphragm preparations after 120 min, but increased the frequency (170 +/- 4%) and amplitude (200 +/- 13%) of miniature end-plate potentials. Quantal content was not influenced by the glucocorticoid treatment. Prednisolone (400 microg/kg) did not change the twitch-tension in rat external popliteal/sciatic nerve-tibialis anterior muscle preparations. However, this steroid (0.3 mM) prevented the neuromuscular blockade by d-tubocurarine (1.45 microM) in mouse preparations by 70 +/- 10% (P0.05). A similar effect (82 +/- 6% protection, P0.05) occurred in rats treated with prednisolone (400 microg/kg) before d-tubocurarine (225 microg/kg). In phrenic nerve-diaphragm preparations, prednisolone (0.3 mM) increased (13 +/- 4%, p0.05) the twitch-tension in the presence of beta-bungarotoxin (1 microM), and prevented the blockade produced by this toxin (0.15 microM) in its third phase of action. This presynaptic facilitatory effect may contribute to the usefulness of prednisolone in myasthenia gravis.
- Published
- 2002